Biotechnology / Education / Hiring / Investing / Startups

Johns Hopkins spinout GrayBug hires first full-time CEO

On top of closing a recent round of nearly $1.5 million in venture funding, Michael O'Rourke joins as the biotech startup's first CEO.

Since April, biotech startup GrayBug has made several important moves, the first being one of three winners in the state’s inaugural InvestMaryland Challenge and winning $100,000 from the state’s venture fund as a result.
On top of closing a recent round of nearly $1.5 million in venture funding, as Baltimore noted in late October, GrayBug recently hired its first full-time CEO, Michael O’Rourke, according to the Baltimore Business Journal.
GrayBug, which develops drug delivery tech for treating macular degeneration, a leading cause of vision loss in Americans over 60 years in age, was spun out of the Johns Hopkins University Wilmer Eye Institute.

Companies: Bio-Rad Laboratories

Before you go...

Please consider supporting to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

Our services Preferred partners The journalism fund

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!


Inside Maryland’s latest effort to support emerging businesses

A Baltimore entrepreneur’s new platform aims to topple tech silos

As a returning citizen, she experienced tech overload. Now she’s fighting to end the digital divide

This Week in Jobs: The kernel of a new career is in these 20 tech opportunities

Technically Media